| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 10/06/2023 | 36.2% | JP Morgan | $40 → $39 | Maintains | Overweight |
| 07/24/2023 | 46.67% | B of A Securities | $44 → $42 | Maintains | Buy |
| 07/24/2023 | 50.17% | Citigroup | $45 → $43 | Maintains | Buy |
| 07/24/2023 | 32.7% | Morgan Stanley | $42 → $38 | Maintains | Equal-Weight |
| 07/24/2023 | 15.24% | Wells Fargo | $43 → $33 | Downgrades | Overweight → Equal-Weight |
| 07/17/2023 | 46.67% | Morgan Stanley | $40 → $42 | Maintains | Equal-Weight |
| 07/03/2023 | 53.66% | B of A Securities | $40 → $44 | Maintains | Buy |
| 04/28/2023 | 39.69% | Barclays | $42 → $40 | Maintains | Equal-Weight |
| 03/30/2023 | 39.69% | B of A Securities | $38 → $40 | Upgrades | Neutral → Buy |
| 03/29/2023 | 39.69% | Exane BNP Paribas | → $40 | Downgrades | Outperform → Neutral |
| 02/14/2023 | 57.15% | Citigroup | $39 → $45 | Maintains | Buy |
| 02/10/2023 | 29.21% | MoffettNathanson | $36 → $37 | Downgrades | Outperform → Market Perform |
| 02/10/2023 | 50.17% | Wells Fargo | $36 → $43 | Maintains | Overweight |
| 02/06/2023 | 39.69% | Morgan Stanley | $35 → $40 | Maintains | Equal-Weight |
| 01/23/2023 | 36.2% | JP Morgan | $38 → $39 | Maintains | Overweight |
| 01/05/2023 | 25.72% | B of A Securities | $22 → $36 | Upgrades | Underperform → Neutral |
| 12/19/2022 | 22.23% | Morgan Stanley | $33 → $35 | Maintains | Equal-Weight |
| 10/25/2022 | 15.24% | Morgan Stanley | $35 → $33 | Maintains | Equal-Weight |
| 09/08/2022 | — | Redburn Partners | Reinstates | → Neutral | |
| 08/25/2022 | — | Exane BNP Paribas | Initiates Coverage On | → Outperform | |
| 07/08/2022 | 29.21% | JP Morgan | $45 → $37 | Maintains | Overweight |
| 07/08/2022 | 15.24% | Wells Fargo | $40 → $33 | Upgrades | Equal-Weight → Overweight |
| 07/07/2022 | 15.24% | Citigroup | $43 → $33 | Maintains | Buy |
| 06/23/2022 | — | Macquarie | Downgrades | Outperform → Neutral | |
| 06/10/2022 | 22.23% | Morgan Stanley | $40 → $35 | Maintains | Equal-Weight |
| 03/21/2022 | 43.18% | Argus Research | → $41 | Upgrades | Hold → Buy |
| 03/14/2022 | 46.67% | Barclays | $47 → $42 | Downgrades | Overweight → Equal-Weight |
| 02/11/2022 | 39.69% | Morgan Stanley | $38 → $40 | Maintains | Equal-Weight |
| 01/27/2022 | 11.75% | B of A Securities | → $32 | Downgrades | Neutral → Underperform |
| 07/22/2021 | 29.21% | B of A Securities | $27 → $37 | Upgrades | Underperform → Neutral |
| 07/22/2021 | 25.72% | Morgan Stanley | $33 → $36 | Maintains | Equal-Weight |
| 07/22/2021 | 32.7% | BMO Capital | $34 → $38 | Maintains | Market Perform |
| 07/02/2021 | 15.24% | Morgan Stanley | $28 → $33 | Maintains | Equal-Weight |
| 04/22/2021 | 4.77% | BMO Capital | $28 → $30 | Downgrades | Outperform → Market Perform |
| 02/11/2021 | -2.22% | Morgan Stanley | $27 → $28 | Maintains | Equal-Weight |
| 12/11/2020 | 15.24% | Barclays | → $33 | Initiates Coverage On | → Overweight |
| 10/22/2020 | -16.19% | MoffettNathanson | → $24 | Upgrades | Neutral → Buy |
| 10/22/2020 | -23.17% | Morgan Stanley | $21 → $22 | Maintains | Equal-Weight |
| 07/23/2020 | -30.16% | Wolfe Research | → $20 | Initiates Coverage On | → Peer Perform |
| 04/22/2020 | -44.12% | CFRA | $25 → $16 | Maintains | Hold |
| 04/21/2020 | -37.14% | Morgan Stanley | $26 → $18 | Maintains | Equal-Weight |
| 04/15/2020 | -33.65% | Citigroup | $28 → $19 | Maintains | Buy |
| 02/12/2020 | -12.69% | CFRA | $22 → $25 | Maintains | Hold |
| 09/24/2019 | -19.68% | Wells Fargo | → $23 | Initiates Coverage On | → Market Perform |
| 07/24/2019 | -5.71% | BMO Capital | $28 → $27 | Maintains | Outperform |
| 01/18/2019 | -16.19% | RBC Capital | $28 → $24 | Downgrades | Outperform → Sector Perform |
| 01/07/2019 | -12.69% | Pivotal Research | $22 → $25 | Upgrades | Hold → Buy |
| 10/24/2018 | -2.22% | BMO Capital | $27 → $28 | Maintains | Outperform |
| 10/19/2018 | -2.22% | Citigroup | $27 → $28 | Maintains | Buy |
| 10/15/2018 | -16.19% | Morgan Stanley | → $24 | Reinstates | → Equal-Weight |
What is the target price for Interpublic Gr of Cos (IPG)?
The latest price target for Interpublic Gr of Cos (NYSE: IPG) was reported by JP Morgan on October 6, 2023. The analyst firm set a price target for $39.00 expecting IPG to rise to within 12 months (a possible 36.20% upside). 18 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Interpublic Gr of Cos (IPG)?
The latest analyst rating for Interpublic Gr of Cos (NYSE: IPG) was provided by JP Morgan, and Interpublic Gr of Cos maintained their overweight rating.
When is the next analyst rating going to be posted or updated for Interpublic Gr of Cos (IPG)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Interpublic Gr of Cos, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Interpublic Gr of Cos was filed on October 6, 2023 so you should expect the next rating to be made available sometime around October 6, 2024.
Is the Analyst Rating Interpublic Gr of Cos (IPG) correct?
While ratings are subjective and will change, the latest Interpublic Gr of Cos (IPG) rating was a maintained with a price target of $40.00 to $39.00. The current price Interpublic Gr of Cos (IPG) is trading at is $28.64, which is out of the analyst's predicted range.